Research and treatment approaches to depression
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
Depression is a major cause of disability worldwide, but we know little about the underlying fundamental biology. Research is hindered by the difficulties of modelling a disorder of higher cognitive functions in animals. Depression can be understood as the interaction of genetic susceptibility and environmental factors; however, current classifications are purely descriptive. The complexity of this field is best approached by rigorous explorations of known candidate systems in conjunction with the use of genomic tools to discover new targets for antidepressants and to predict therapeutic outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies using PET imaging 87 as well as analyses of post-mortem brain tissue 88 have indicated neuroinflammation and microglial activation in the central nervous systems of patients with MDD.”
From Major depressive disorder (2016) · cites this paper as [87]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Learned helplessness in humans: Critique and reformulation.
Abramson, L. Y., Seligman, M. E., & Teasdale, J. D. (1978) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.87.1.49 · Cited by 7,121
(1996) · Cited by 6,884
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162 · cited 1×
“have identified a functional polymorphism in the upstream regulatory region of the serotonin transporter gene that affects transcriptional efficienc”
BackgroundA Syndrome produced by Diverse Nocuous Agents
SELYE, H. (1936) · Nature · doi:10.1038/138032a0 · Cited by 3,903
Genetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431 · cited 1×
“Major depression has an estimated heritability of 31–42%, which is much lower than the 70% heritability estimated for schizophrenia and bipolar disorde”
BackgroundGenetic Dissection of Complex Traits
Lander, E. S., & Schork, N. J. (1994) · Science · doi:10.1126/science.8091226 · Cited by 3,413
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Cross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302 · cited 1×
“A detailed and well-controlled cross-national epidemiological study examined lifetime rates of depression in ten countrie”
BackgroundExcess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881 · cited 1×
“Depressed patients have an increased risk of premature death when compared with control subject”
Background
Research works printed but not linked: 1
- Nobel Foundation. Nobel Lectures — Physiology or Medicine, 1901–1970 (Elsevier, Amsterdam, 1970).
Cited by
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S., Egan, M. F., Mattay, V. S., Hariri, A. R., & Weinberger, D. R. (2005) · Nature Neuroscience · doi:10.1038/nn1463 · Cited by 1,980
“dtd" [ ]> Depression is among the four leading causes of disability and disease burden throughout the world and is associated with serious medical conditions and mortality across the lifespa”
BackgroundBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
“Significant progress has been made in our ability to treat depression, but not all depressed patients respond to available antidepressants, and the therapeutic response requires several weeks or months of treatment (Duman et al., 2000; Wong and Licinio, 2001).”
BackgroundAssessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198
Epigenetic transmission of the impact of early stress across generations
Franklin, T. B., Russig, H., Weiss, I. C., Gräff, J., Linder, N., Michalon, A., Vizi, S., & Mansuy, I. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.036 · Cited by 1,125
Metalearning and neuromodulation
Doya, K. (2002) · Neural Networks · doi:10.1016/s0893-6080(02)00044-8 · Cited by 704
“13 ( Wang & Licinio, 2001 ). The situation depicted in Figure 7(b), where the optimal policy is doing nothing with a small setting of the discount factor γ ,c an be a model of depression.”
BackgroundFluoxetine targets early progenitor cells in the adult brain
Encinas, J. M., Vaahtokari, A., & Enikolopov, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601992103 · Cited by 637
Cryan, J. F., & Mombereau, C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001457 · Cited by 616
“Using genetically modified mice to study depression Depression: still an unmet medical need Depression is one of the most serious disorder in today's society”
BackgroundThe Effects of Psychological Stress on Depression
Yang, L., Zhao, Y., Wang, Y., Liu, L., Zhang, X., Li, B., & Cui, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x1304150831150507 · Cited by 589
Preclinical models: status of basic research in depression
Nestler, E. J., Gould, E., & Manji, H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01405-1 · Cited by 558
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Wang, J.-W., David, D. J., Monckton, J. E., Battaglia, F., & Hen, R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3632-07.2008 · Cited by 550
“…the action of antidepressants are still unclear: SSRIs require at least 2– 4 weeks of administration before achieving therapeutic benefits (Wong and Licinio, 2001), despite the fact that serotonin levels rise rapidly after acute administration of SSRIs in both primates and rodents…”
BackgroundBDNF in schizophrenia, depression and corresponding animal models
Angelucci, F., Brenè, S., & Mathé, A. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001637 · Cited by 548
Antidepressants recruit new neurons to improve stress response regulation
Surget, A., Tanti, A., Leonardo, E. D., Laugeray, A., Rainer, Q., Touma, C., Palme, R., Griebel, G., Ibarguen-Vargas, Y., Hen, R., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.48 · Cited by 471
Leptin: A potential novel antidepressant
Lu, X.-Y., Kim, C. S., Frazer, A., & Zhang, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508901103 · Cited by 446
Uchida, S., Hara, K., Kobayashi, A., Otsuki, K., Yamagata, H., Hobara, T., Suzuki, T., Miyata, N., & Watanabe, Y. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.023 · Cited by 398
“Anhedonia , diminished interest or pleasure, is one of the core symptoms of major depression (Wong and Licinio, 2001).”
Ridder, S., Chourbaji, S., Hellweg, R., Urani, A., Zacher, C., Schmid, W., Zink, M., Hörtnagl, H., Flor, H., Henn, F. A., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0736-05.2005 · Cited by 382
“GR / and YGR mice show altered levels of hippocampal BDNF expression Because downregulation of BDNF has been postulated to play a critical role in the pathogenesis of depression disorders (Duman et al., 1997; Altar, 1999; Wong and Licinio, 2001; Nestler et al., 2002; Cryan and Mombereau, 2004), we analyzed the levels…”
MethodGlycogen Synthase Kinase-3 (GSK3) in Psychiatric Diseases and Therapeutic Interventions
Jope, R., & Roh, M.-S. (2006) · Current Drug Targets · doi:10.2174/1389450110607011421 · Cited by 382
Adachi, M., Barrot, M., Autry, A. E., Theobald, D., & Monteggia, L. M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.019 · Cited by 380
The recent progress in animal models of depression
Wang, Q., Timberlake, M. A., Prall, K., & Dwivedi, Y. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.008 · Cited by 370
Robinson, R. G., Jorge, R. E., Moser, D. J., Acion, L., Solodkin, A., Small, S. L., Fonzetti, P., Hegel, M., & Arndt, S. (2008) · JAMA · doi:10.1001/jama.299.20.2391 · Cited by 355
“In addition, it has been hypothesized that antidepressant effects on neuroplasticity(50) mediate both recovery from depression as well as motor and cognitive recovery through different mechanisms.(51) Perhaps prevention of depression may be another example of this alternative mode of action.”
BackgroundSong, L., Che, W., Min-wei, W., Murakami, Y., & Matsumoto, K. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.01.004 · Cited by 332
Kraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenweider, F. X. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.010 · Cited by 323
“The relevance of serotonin (5-hydroxytryptamine, 5-HT) neurotransmission in the pathogenesis and treatment of major depression is further supported by the finding that depletion of tryptophan, a precursor in the biosynthesis of serotonin, induced depression in vulnerable individuals (11) and that SSRIs have strong ant…”
BackgroundWong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295
“We used the following procedures to identify a list of SNPs statistically associated with a diagnosis of depression: (1) study population and controls were randomly divided into two groups: discovery and replication samples; (2) significance level was set at P≤0.”
MethodSelf-citationNo stress please! Mechanisms of stress hyporesponsiveness of the maternal brain
Slattery, D. A., & Neumann, I. D. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.145896 · Cited by 292
“Furthermore, according to the monoamine hypothesis, depression results from underactivity of noradrenaline and serotonin systems, and accepted treatment is generally with their respective reuptake inhibitors (Ressler & Nemeroff, 1999; Wong & Licinio, 2001).”
BackgroundA renaissance in trace amines inspired by a novel GPCR family
Lindemann, L., & Hoener, M. C. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.007 · Cited by 287
Pathophysiology of depression and mechanisms of treatment
Brigitta, B. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.1/bbondy · Cited by 286
“It has been repeatedly suggested that this variable course of the disorder might be explained by inflammatory processes.(10) Traditionally, both stress and depression have been associated with impaired immune function and increased susceptibility to infectious and neoplastic disease.”
BackgroundDias, B. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00198-9 · Cited by 274
“The pathogenesis of this disease as well as the mechanisms of action underlying currently available antidepressant treatments are as yet unclear (Wong and Licinio, 2001).”
BackgroundLow-Serotonin Levels Increase Delayed Reward Discounting in Humans
Schweighofer, N., Bertin, M., Shishida, K., Okamoto, Y., Tanaka, S. C., Yamawaki, S., & Doya, K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4982-07.2008 · Cited by 260
Ageing and neurodegenerative diseases
Hung, C.-W., Chen, Y.-C., Hsieh, W.-L., Chiou, S.-H., & Kao, C.-L. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.006 · Cited by 247
Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression
Pezawas, L., Meyer-Lindenberg, A., Goldman, A. L., Verchinski, B. A., Chen, G., Kolachana, B. S., Egan, M. F., Mattay, V. S., Hariri, A. R., & Weinberger, D. R. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.32 · Cited by 238
From monoamines to genomic targets: a paradigm shift for drug discovery in depression
Wong, M.-L., & Licinio, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1303 · Cited by 225
Self-citationDannlowski, U., Ohrmann, P., Konrad, C., Domschke, K., Bauer, J., Kugel, H., Hohoff, C., Schöning, S., Kersting, A., Baune, B. T., et al. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008973 · Cited by 216
“Converging lines of research suggest that monoaminergic signal transduction plays a crucial role in the aetiology of major depression (Wong and Licinio, 2001).”
BackgroundWhooley, O. (2010) · Sociology of Health & Illness · doi:10.1111/j.1467-9566.2010.01230.x · Cited by 194
“Keywords: psychiatry, diagnosis, workarounds, sociological ambivalence”
BackgroundMoretti, M., Colla, A., de Oliveira Balen, G., dos Santos, D. B., Budni, J., de Freitas, A. E., Farina, M., & Severo Rodrigues, A. L. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.11.009 · Cited by 210
“, depression, post-traumatic stress disorder) are twice as prevalent inwomen compared tomen (Wong and Licinio, 2001).”
BackgroundWatt, D. F., & Panksepp, J. (2009) · Neuropsychoanalysis · doi:10.1080/15294145.2009.10773593 · Cited by 208
Machado, D. G., Bettio, L. E. B., Cunha, M. P., Santos, A. R. S., Pizzolatti, M. G., Brighente, I. M. C., & Rodrigues, A. L. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.021 · Cited by 208
“In addition, most therapies require several weeks of treatment before improvement of signs and symptoms is observed and there are numerous side effects caused by antidepressants (Wong and Licinio, 2001).”
BackgroundIonotropic Glutamate Receptors & CNS Disorders
Bowie, D. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708784083821 · Cited by 202
Alboni, S., van Dijk, R. M., Poggini, S., Milior, G., Perrotta, M., Drenth, T., Brunello, N., Wolfer, D. P., Limatola, C., Amrein, I., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2015.142 · Cited by 207
Elizalde, N., Gil-Bea, F. J., Ramírez, M. J., Aisa, B., Lasheras, B., Del Rio, J., & Tordera, R. M. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1035-1 · Cited by 200
“Depression is a chronic mental disorder mainly characterized by depressed mood and anhedonia and often coupled to sleep disturbances, low self-esteem, guilty feelings, and suicidal tendencies (Wong and Licinio 2001).”
BackgroundKozisek, M. E., Middlemas, D., & Bylund, D. B. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.07.001 · Cited by 205
Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus
Biggio, F., Gorini, G., Utzeri, C., Olla, P., Marrosu, F., Mocchetti, I., & Follesa, P. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000200 · Cited by 203
“Thus, at variance with acute antidepressant drugs (Duman et al. 1997 ; Wang et al. 2008 ; Wong & Licinio, 2001), acute VNS affects cell proliferation and hippocampal plasticity.”
BackgroundLandgraf, R., Keßler, M. S., Bunck, M., Murgatroyd, C., Spengler, D., Zimbelmann, M., Nußbaumer, M., Czibere, L., Turck, C. W., Singewald, N., et al. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.003 · Cited by 199
An analysis of selected normative tooth proportions.
Gillen, R. J., Schwartz, R. S., Hilton, T. J., & Evans, D. B. (1994) · PubMed · Cited by 250
Surget, A., Wang, Y., Leman, S., Ibarguen-Vargas, Y., Edgar, N., Griebel, G., Belzung, C., & Sibille, E. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.76 · Cited by 194
Rodent models in depression research: Classical strategies and new directions
Pollak, D. D., Rey, C. E., & Monje, F. J. (2010) · Annals of Medicine · doi:10.3109/07853891003769957 · Cited by 187
Mice selected for high versus low stress reactivity: A new animal model for affective disorders
Touma, C., Bunck, M., Glasl, L., Nussbaumer, M., Palme, R., Stein, H., Wolferstätter, M., Zeh, R., Zimbelmann, M., Holsboer, F., et al. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.03.013 · Cited by 190
“About 240 million people are affected worldwide, reflecting a high lifetime prevalence of about 17% (Wong and Licinio, 2001; Nestler et al., 2002; Kessler et al., 2003).”
BackgroundInfluentialPeng, W.-H., Lo, K.-L., Lee, Y.-H., Hung, T.-H., & Lin, Y.-C. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.08.003 · Cited by 182
Kole, M. H. P., Swan, L., & Fuchs, E. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02136.x · Cited by 181
Jabbi, M., Korf, J., Kema, I. P., Hartman, C., van der Pompe, G., Minderaa, R. B., Ormel, J., & den Boer, J. A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001975 · Cited by 175
Andrus, B. M., Blizinsky, K., Vedell, P. T., Dennis, K., Shukla, P. K., Schaffer, D. J., Radulovic, J., Churchill, G. A., & Redei, E. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.119 · Cited by 178
Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
Jope, R. S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00016 · Cited by 176
5-HTTLPR Biases Amygdala Activity in Response to Masked Facial Expressions in Major Depression
Dannlowski, U., Ohrmann, P., Bauer, J., Deckert, J., Hohoff, C., Kugel, H., Arolt, V., Heindel, W., Kersting, A., Baune, B. T., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301411 · Cited by 173
Central functions of neuropeptide Y in mood and anxiety disorders
Wu, G., Feder, A., Wegener, G., Bailey, C., Saxena, S., Charney, D., & Mathé, A. A. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.628314 · Cited by 163
“4 Exercise training Physical activity has been shown to have beneficial effects on depressive symptom levels [108,109].”
BackgroundLicinio, J., O'Kirwan, F., Irizarry, K., Merriman, B., Thakur, S., Jepson, R., Lake, S., Tantisira, K. G., Weiss, S. T., & Wong, M.-L. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001587 · Cited by 168
Self-citationCapra, J. C., Cunha, M. P., Machado, D. G., Zomkowski, A. D. E., Mendes, B. G., Santos, A. R. S., Pizzolatti, M. G., & Rodrigues, A. L. S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.043 · Cited by 164
“Depression is a commonmood disorder associated with high rates of chronicity, relapse, and recurrence; psychosocial and physical impairment; and suicide (Wong and Licinio, 2001).”
BackgroundChourbaji, S., Hellweg, R., Brandis, D., Zörner, B., Zacher, C., Lang, U. E., Henn, F. A., Hörtnagl, H., & Gass, P. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.11.002 · Cited by 165
van der Hart, M. G. C., Czéh, B., de Biurrun, G., Michaelis, T., Watanabe, T., Natt, O., Frahm, J., & Fuchs, E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001130 · Cited by 158
A Possible Link between Food and Mood: Dietary Impact on Gut Microbiota and Behavior in BALB/c Mice
Pyndt Jørgensen, B., Hansen, J. T., Krych, L., Larsen, C., Klein, A. B., Nielsen, D. S., Josefsen, K., Hansen, A. K., & Sørensen, D. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103398 · Cited by 149
Branchi, I. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.08.011 · Cited by 156
“These discoveries — on the basis of the ex iuvantibus principle, by which the cause of a given disease is inferred from themechanism of action (real or supposed) of a treatment with therapeutic effects (real or supposed) on that disease — led to a major theory of depression known as the monoamine hypothesis (Heninger…”
BackgroundPotentials of Curcumin as an Antidepressant
Kulkarni, S. K., Dhir, A., & Akula, K. K. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.137 · Cited by 151
“1235 Major depression represents the most common and proliferating health problem worldwide[24,25], and has an estimated lifetime prevalence of about 15–20%[26,27,28].”
BackgroundBinfaré, R. W., Rosa, A. O., Lobato, K. R., Santos, A. R. S., & Rodrigues, A. L. S. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.02.003 · Cited by 158
Zomkowski, A. D. E., Rosa, A. O., Lin, J. H. X., Santos, A. R. S., Calixto, J. Β., & Rodrigues, A. L. S. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.041 · Cited by 159
“A large number of experimental and clinical studies indicate that the serotonin (5-HT) system is strongly implicated in the neural regulation of mood and several pieces of evidence have implicated abnormalities in 5-HT neurotransmission in the pathophysiology of depression [13,53].”
BackgroundZhang, J., Huang, X.-Y., Ye, M.-L., Luo, C.-X., Wu, H.-Y., Hu, Y., Zhou, Q.-G., Wu, D.-L., Zhu, L.-J., & Zhu, D.-Y. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5880-09.2010 · Cited by 141
“The noradrenergic system is another monoaminergic system implicated in anxiety (Wong and Licinio, 2001; Santarelli et al., 2003); we therefore assessed whether nNOS is associated with the behavioral effect of noradrenaline-reuptake inhibitors (NRIs).”
BackgroundForebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than “depressive”
Zörner, B., Wolfer, D. P., Brandis, D., Kretz, O., Zacher, C., Madani, R., Kadow, I. C. G., Lipp, H., Klein, R., Henn, F. A., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00418-9 · Cited by 165
“Recent studies have provided evidence for a neurotrophin hypothesis of depression and antidepressive treatment (Altar 1999; Duman 2002; Duman et al 1997; Licinio and Wong 2002; Manji et al 2001; Nestler et al 2002; Vaidya and Duman 2001; Wong and Licinio 2001).”
BackgroundMachado, D. G., Cunha, M. P., Neis, V. B., Balen, G. O., Colla, A. R. D. S., Bettio, L. E. B., Oliveira‐Giacomelli, Á., Pazini, F. L., Dalmarco, J. B., Simionatto, E. L., et al. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.09.028 · Cited by 158
Natural polyphenols in the management of major depression
Pathak, L., Agrawal, Y., & Dhir, A. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.794783 · Cited by 142
“Major depression is a serious medical illness that affects both developed and developing countries [18,19], and has an estimated lifetime prevalence of about 15 -- 20% [20-22].”
BackgroundPar-4 Links Dopamine Signaling and Depression
Park, S. K., Nguyen, M. D., Fischer, A., Luke, M. P.-S., Affar, E. B., Dieffenbach, P. B., Tseng, H.-C., Shi, Y., & Tsai, L. (2005) · Cell · doi:10.1016/j.cell.2005.05.031 · Cited by 157
“However, since clinical effects of antidepressants are usually significantly delayed, it is now believed that an adaptation of downstream events, including changes in gene expression and/or modification of other neurotransmitter systems, due to chronic treatment underlies their antidepressant efficacy (Manji et al., 2…”
Molecular biomarkers of depression
Gururajan, A., Clarke, G. A., Dinan, T. G., & Cryan, J. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.011 · Cited by 153
Ginsenosides: A Potential Neuroprotective Agent
Zheng, M., Xin, Y., Li, Y., Xu, F., Xi, X., Guo, H., Cui, X., Cao, H., Zhang, X., & Han, C. (2018) · BioMed Research International · doi:10.1155/2018/8174345 · Cited by 142
David, D. J. P., Klemenhagen, K. C., Holick, K. A., Saxe, M., Mendez‐David, I., Santarelli, L., Craig, D. A., Zhong, H., Swanson, C. J., Hegde, L. G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109678 · Cited by 147
“faced in treating these disorders with selective serotonin reuptake inhibitors (SSRIs) is that the therapeutic response develops slowly (3 to 4 weeks), side effects often occur and there is a significant percentage of non-responders (≈30%) (Wong and Licinio, 2001).”
BackgroundInteraction of zinc with antidepressants in the tail suspension test
Cunha, M. P., Machado, D. G., Bettio, L. E. B., Capra, J. C., & Rodrigues, A. L. S. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.09.006 · Cited by 145
Verma, P., Hellemans, K. G. C., Choi, F. Y., Yu, W., & Weinberg, J. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.11.002 · Cited by 136
“Indeed, depression is the most common psychiatric disorder [1].”
Animal models of depression: are there any?
O'Neil, M. F., & Moore, N. A. (2003) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.496 · Cited by 133
Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety
Rainer, Q., Xia, L., Guilloux, J.-P., Gabriel, C., Mocaër, E., Hen, R., Enhamre, E., Gardier, A. M., & David, D. J. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000356 · Cited by 122
“%) of non-responders (Wong & Licinio, 2001).”
BackgroundMachado, D. G., Kaster, M. P., Binfaré, R. W., Dias, M., Santos, A. R. S., Pizzolatti, M. G., Brighente, I. M. C., & Rodrigues, A. L. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.11.004 · Cited by 149
“Currently available therapy for depression treatment is often associated with several undesirable side effects, and it is effective only in a certain portion of the population (Wong and Licinio, 2001; Nestler et al., 2002).”
BackgroundZhong, P., Wang, W., Pan, B., Liu, X., Zhang, Z., Long, J. Z., Zhang, H., Cravatt, B. F., & Liu, Q.-S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.24 · Cited by 143
“Clinically antidepressants have delayed onset in their antidepressant actions, suggesting that slow neurochemical and other changes are required for their clinical effects (Wong and Licinio, 2001).”
BackgroundCzeh, B., Simon, M., van der Hart, M. G., Schmelting, B., Hesselink, M. B., & Fuchs, E. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300581 · Cited by 136
“Depressive disorders are common and life-threatening illnesses, but little is known about the underlying fundamental biology (Wong and Licinio, 2001; Nestler et al, 2002).”
Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin
Yi, L., Li, J., Li, Y., Pan, Y., Xu, Q., & Kong, L. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.01.007 · Cited by 145
Ye, Y., Wang, G., Wang, H., & Wang, X. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.055 · Cited by 146
Mitsukawa, K., Mombereau, C., Loetscher, E., Uzunov, D. P., van der Putten, H., Flor, P. J., & Cryan, J. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300926 · Cited by 140
“Stress-related psychiatric disorders such as depression and anxiety disorders are an enormous public health concern ( Wong and Licinio, 2001, 2004 ).”
BackgroundEarly Life Stress, Depression And Parkinson’s Disease: A New Approach
Dallé, E., & Mabandla, M. V. (2018) · Molecular Brain · doi:10.1186/s13041-018-0356-9 · Cited by 144
Dettling, A. C., Feldon, J., & Pryce, C. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01460-9 · Cited by 145
“There is growing evidence that adverse early life events constitute one of the major risk factors for the development of mood and anxiety disorders in adolescence and adulthood (Bernet and Stein 1999; Glaser 2000; Heim and Nemeroff 2001; Heim et al 1997; Wong and Licinio 2001).”
BackgroundPerceived stress and depression in 45 low- and middle-income countries
Cristóbal-Narváez, P., Haro, J. M., & Koyanagi, A. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.04.020 · Cited by 142
Sheng, Z., Kawano, J., Yanai, A., Fujinaga, R., Tanaka, M., Watanabe, Y., & Shinoda, K. (2004) · Neuroscience Research · doi:10.1016/j.neures.2004.02.011 · Cited by 138
Depression, antidepressants and suicidality: a critical appraisal
Licinio, J., & Wong, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1634 · Cited by 146
“The point prevalence (the measure of a condition in a population at a given point in time) is 3% (2% in men, 4% in women”
BackgroundSelf-citationEvidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression.
Koo, J. W., & Duman, R. S. (2009) · PubMed · Cited by 155
The cholinergic system and depression
Dagytė, G., den Boer, J. A., & Trentani, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.023 · Cited by 138
“In contrast, many urrently used antidepressant drugs, such as selective serotonin euptake inhibitors (SSRI), noradrenaline reuptake inhibitors (NRI), erotonin and noradrenaline reuptake inhibitors (SNRI), tricyclics nd monoamine oxidase inhibitors (MAOI) potentiate the brain’s onoaminergic system and elevate the monoa…”
BackgroundSerotonergic genes modulate amygdala activity in major depression
Dannlowski, U., Ohrmann, P., Bauer, J., Kugel, H., Baune, B. T., Hohoff, C., Kersting, A., Arolt, V., Heindel, W., Deckert, J., et al. (2007) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2006.00297.x · Cited by 128
“…5-HTTLPR, amygdala, depression, emotion, fMRI, rs25531, serotonin Received 12 August 2006, revised 17 November 2006, accepted for publication 17 November 2006 Converging evidence suggests that the serotonergic system plays a crucial role in the etiology of affective disorders (Wong & Licinio 2001).”
BackgroundAntidepressant-like effects of piperine and its derivative, antiepilepsirine
Li, S., Wang, C., Li, W., Koike, K., Nikaido, T., & Wang, M. (2007) · Journal of Asian Natural Products Research · doi:10.1080/10286020500384302 · Cited by 133
Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors
Albizu, L., Holloway, T., González-Maeso, J., & Sealfon, S. C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.023 · Cited by 119
“Altered serotonin and dopamine neurotransmission has been implicated in various psychiatric disorders including anxiety, depression and schizophrenia (de Almeida et al., 2008; Kienast and Heinz, 2006; Mann et al., 2001; Wong and Licinio, 2001).”
BackgroundLamiay, J., Schneider, B., Loric, S., Prada, M. D., & Kellermann, O. (2006) · The FASEB Journal · doi:10.1096/fj.06-5724com · Cited by 131
Khan, M. F., Kader, F. B., Arman, M., Ahmed, S., Lyzu, C., Sakib, S. A., Tanzil, S. M., Zim, A. F. M. I. U., Imran, M. A. S., Venneri, T., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110774 · Cited by 122
Jiao, X., Xiao, Y., Li, Y., Liang, M., Xie, X., Wang, X., & Tang, B. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01106 · Cited by 118
Bruno, V., Battaglia, G., Ksiazek, I., van der Putten, H., Catania, M. V., Giuffrida, R., Lukic, S., Leonhardt, T., Inderbitzin, W., Gasparini, F., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06413.2000 · Cited by 124
Machado, D. G., Neis, V. B., Balen, G. O., Colla, A. R. D. S., Cunha, M. P., Dalmarco, J. B., Pizzolatti, M. G., Prediger, R. D., & Rodrigues, A. L. S. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.08.016 · Cited by 127
Wnt2 Expression and Signaling Is Increased by Different Classes of Antidepressant Treatments
Okamoto, H., Voleti, B., Banasr, M., Sarhan, M., Duric, V., Girgenti, M. J., DiLeone, R. J., Newton, S. S., & Duman, R. S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.023 · Cited by 116
Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics
Fang, S., Wu, Z., Guo, Y., Zhu, W., Wan, C., Yuan, N., Chen, J., Hao, W., Mo, X., Guo, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1193053 · Cited by 96
Metadata
- Authors
- Wong, M.-L., & Licinio, J.
- Affiliations
- University of California, Los Angeles (US)
- ORCID
- Wong, Ma-Li
- Venue
- Nature Reviews Neuroscience
- Published
- 2001-05
- Volume
- 2
- Issue
- 5
- Pages
- 343-351
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2102343823
- Cited by
- 656
- References
- 104
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 16 · 2023: 22 · 2022: 18 · 2021: 22 · 2020: 14 · 2019: 20 · 2018: 33 · 2017: 29 · 2016: 28 · 2015: 24 · 2014: 39 · 2013: 30 · 2012: 41
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- depression, antidepressant targets, genetic susceptibility, environmental factors, animal models of depression, cognitive impairment, depression classification, genomic tools, therapeutic outcome prediction
- MeSH terms
- Animals, Antidepressive Agents, Brain Chemistry, Depression, Humans, Drug Design, Causality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.